Althea Group Holdings Ltd
ASX:AGH

Watchlist Manager
Althea Group Holdings Ltd Logo
Althea Group Holdings Ltd
ASX:AGH
Watchlist
Price: 0.0205 AUD -2.38% Market Closed
Market Cap: 20.5m AUD

Relative Value

AGH doesn't have a meaningful market cap.

The Relative Value of one AGH stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.0205 AUD, Althea Group Holdings Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AGH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
84
Median 3Y
1.7
Median 5Y
2.7
Industry
2.6
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-3.2
Industry
21.6
vs History
vs Industry
Median 3Y
-6.2
Median 5Y
-8.6
Industry
16.5
vs History
vs Industry
Median 3Y
-6.7
Median 5Y
-9.6
Industry
22.5
vs History
vs Industry
1
Median 3Y
1.7
Median 5Y
3.5
Industry
2.3
vs History
74
vs Industry
81
Median 3Y
2
Median 5Y
2.9
Industry
2.9
vs History
65
vs Industry
82
Median 3Y
3.4
Median 5Y
5.2
Industry
5.5
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-6.2
Industry
13
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-6.2
Industry
16.6
vs History
vs Industry
Median 3Y
-6.4
Median 5Y
-9.1
Industry
15.8
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-7.7
Industry
19.1
vs History
47
vs Industry
49
Median 3Y
2
Median 5Y
2.5
Industry
1.9

Multiples Across Competitors

AGH Competitors Multiples
Althea Group Holdings Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Althea Group Holdings Ltd
ASX:AGH
20.5m AUD 1.3 -2.5 -6 -6
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.6 36.6 39.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
515.3B USD 5.6 20.5 16.8 21.7
CH
Roche Holding AG
SIX:ROG
258.6B CHF 4.2 27.4 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
211.7B GBP 4.9 30.1 108.3 158.5
CH
Novartis AG
SIX:NOVN
208.5B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.5 9.5 11
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
150.3B USD 2.4 15.3 7.7 10.5
P/E Multiple
Earnings Growth PEG
AU
Althea Group Holdings Ltd
ASX:AGH
Average P/E: 24.1
Negative Multiple: -2.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.6
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.5
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.4
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.1
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.5
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15.3
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Althea Group Holdings Ltd
ASX:AGH
Average EV/EBITDA: 438.9
Negative Multiple: -6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.6
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.8
9%
1.9
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.5
2%
4.7
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.7
1%
7.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Althea Group Holdings Ltd
ASX:AGH
Average EV/EBIT: 1 881.3
Negative Multiple: -6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.7
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.5
8%
1.3